LOXL2 was shown to mediate its pathogenic effects in HCC angiogenesis via vasculogenic mimicry signalling, cytoskeleton reorganization, and bone-marrow derived cell recruitment59,60. Here, LOXL2 is linked to hepatocellular carcinoma.